ATE392887T1 - Stabilisierte arzneizusammensetzungen zur parenteralen vearbreichung - Google Patents

Stabilisierte arzneizusammensetzungen zur parenteralen vearbreichung

Info

Publication number
ATE392887T1
ATE392887T1 AT01308284T AT01308284T ATE392887T1 AT E392887 T1 ATE392887 T1 AT E392887T1 AT 01308284 T AT01308284 T AT 01308284T AT 01308284 T AT01308284 T AT 01308284T AT E392887 T1 ATE392887 T1 AT E392887T1
Authority
AT
Austria
Prior art keywords
compounds
parenteral administration
lambda
warm
alpha
Prior art date
Application number
AT01308284T
Other languages
English (en)
Inventor
William David Steber
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of ATE392887T1 publication Critical patent/ATE392887T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT01308284T 2000-10-10 2001-09-28 Stabilisierte arzneizusammensetzungen zur parenteralen vearbreichung ATE392887T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23892500P 2000-10-10 2000-10-10

Publications (1)

Publication Number Publication Date
ATE392887T1 true ATE392887T1 (de) 2008-05-15

Family

ID=22899893

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01308284T ATE392887T1 (de) 2000-10-10 2001-09-28 Stabilisierte arzneizusammensetzungen zur parenteralen vearbreichung

Country Status (9)

Country Link
EP (1) EP1197207B1 (de)
JP (1) JP4221170B2 (de)
AT (1) ATE392887T1 (de)
CA (1) CA2358361C (de)
CY (1) CY1108145T1 (de)
DE (1) DE60133706T2 (de)
DK (1) DK1197207T3 (de)
ES (1) ES2304371T3 (de)
PT (1) PT1197207E (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2852843B1 (fr) * 2003-03-24 2008-05-23 Karim Ioualalen Systeme galenique permettant le masquage du gout
FR2913884A1 (fr) * 2007-03-21 2008-09-26 Oralance Pharma Sa Systeme galenique hydrophobe non ionisable
ITUB20153652A1 (it) * 2015-09-16 2017-03-16 Fatro Spa Microsfere contenenti lattoni macrociclici antielminitici
KR102101969B1 (ko) 2017-09-06 2020-04-22 (주)인벤티지랩 목시덱틴을 포함하는 마이크로 입자 및 이의 제조 방법
MX2021013429A (es) 2019-05-03 2021-12-10 Intervet Int Bv Composiciones farmaceuticas inyectables y usos de las mismas.
EP4153133B1 (de) 2020-05-20 2023-11-08 Intervet International B.V. Injizierbare pharmazeutische zusammensetzungen und verwendungen davon
WO2024003291A1 (en) 2022-06-30 2024-01-04 Virbac Deslorelin use in chemical castration of a non-human mammal related to pk/pd interaction

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5213810A (en) * 1990-03-30 1993-05-25 American Cyanamid Company Stable compositions for parenteral administration and method of making same
US5733566A (en) * 1990-05-15 1998-03-31 Alkermes Controlled Therapeutics Inc. Ii Controlled release of antiparasitic agents in animals
EP0525307B1 (de) * 1991-07-23 1996-03-06 American Cyanamid Company Stabile Zusammensetzungen für parenterale Verabrechung und ihre Verwendung
GB2310801A (en) * 1996-03-04 1997-09-10 Merck & Co Inc Process for removing an organic solvent from lactide-glycoside copolymer microspheres

Also Published As

Publication number Publication date
EP1197207B1 (de) 2008-04-23
DE60133706T2 (de) 2009-07-02
EP1197207A3 (de) 2003-02-05
CA2358361C (en) 2009-08-11
CY1108145T1 (el) 2013-03-13
DE60133706D1 (de) 2008-06-05
DK1197207T3 (da) 2008-08-04
ES2304371T3 (es) 2008-10-16
PT1197207E (pt) 2008-07-01
JP2002161033A (ja) 2002-06-04
AU784023B2 (en) 2006-01-19
CA2358361A1 (en) 2002-04-10
AU7827301A (en) 2002-04-11
EP1197207A2 (de) 2002-04-17
JP4221170B2 (ja) 2009-02-12

Similar Documents

Publication Publication Date Title
CY1108145T1 (el) Σταθερες συνθεσεις για παρεντερικη χορηγηση
DK0525307T3 (da) Stabile præparater til parenteral indgivelse og deres anvendelse
DK1087960T3 (da) Makrocykliske analoger og fremgangsmåder til deres anvendelse og fremstilling
ATE324039T1 (de) Verwendung von spinosad oder einer zusammensetzung enthaltend spinosad
DK0810823T3 (da) Sammensætning til bekæmpelse af parasitter
NO20052408L (no) Farmasoytisk formulering av olanzapin
EE200100433A (et) Klaritromütsiini, rasv- ja hüdrofiilse komponendisegu sisaldav farmatseutiline preparaat, meetod selle valmistamiseks ning kasutamine
DK1383756T3 (da) Cumarinderivater til anvendelse som antikoagulanter
WO2004098594A3 (en) Dosage form containing pantoprazole as active ingredient
AP2004003106A0 (en) Synergistic insecticidal mixtures.
DK0930077T3 (da) Cyclodextrinpræparater indeholdende et avermectin- eller milbemycinderivat
DE69331007T2 (de) Difluoroavermectin-derivate
WO2004098577A3 (en) Dosage form containing (s)-pantoprazole as active ingredient
BR0109891A (pt) Composição farmaceutica contendo derivado de camptotecina e substância de ajuste de ph
WO2004072037A8 (en) 2,3'-bipyridines derivatives as selective cox-2 inhibitors
WO2005027903A8 (en) Polyether brevetoxin derivatives as a treatment for neurotoxic shellfish poisoning and ciguatera fish poisoning
DK1100463T3 (da) Injicerbare formuleringer indeholdende ramoplanin

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1197207

Country of ref document: EP

EEIH Change in the person of patent owner